Crestor Lawsuit
π 2026 Update: Recent Developments in Drug Lawsuits
Since the original article was published, several significant changes have occurred in the landscape of drug lawsuits. Notable cases have emerged, affecting patients and pharmaceutical companies alike. The earlier article continues further down the page and provides essential background information.
π₯ Ozempic Lawsuits Consolidation
As of June 2026, 3,763 lawsuits related to Ozempic have been consolidated in federal court in Pennsylvania. These lawsuits allege that Ozempic and related drugs can cause severe gastrointestinal injuries and vision loss. This consolidation allows for more efficient processing of claims and streamlines the legal proceedings for affected individuals.
- βοΈ Eligibility: Individuals who developed severe gastrointestinal injuries or vision loss after taking Ozempic may be eligible to file a lawsuit.
π° Gardasil Lawsuit Settlement
In June 2026, Merck reached a settlement of over $50 million to resolve more than 200 Gardasil-related cases. This includes cases previously dismissed in North Carolina and a long-standing case in Los Angeles. The settlement indicates a significant financial commitment by Merck to address claims regarding the vaccine's safety.
- π΅ Financial Impact: The settlement reflects the legal costs and concerns surrounding Gardasil, which may influence future vaccine litigation.
π§ Depo-Provera Lawsuit Growth
The multidistrict litigation (MDL) for Depo-Provera has expanded to over 5,500 cases by June 2026. Plaintiffs allege a link between the contraceptive and the development of brain tumors. This growth indicates a rising concern regarding the drug's safety and its potential health risks.
- π Claims: The lawsuits focus on the alleged connection between Depo-Provera and serious health issues, leading to increased scrutiny of the contraceptive.
πΌ Strive Pharmacy Antitrust Lawsuit
On January 14, 2026, Strive Specialties Inc. filed an antitrust complaint against Eli Lilly and Novo Nordisk. The complaint accuses these companies of suppressing competition in the GLP-1 weight-loss drug market. This case highlights ongoing tensions in the pharmaceutical industry regarding competition and market practices.
- βοΈ Market Impact: The outcome of this lawsuit may influence pricing and availability of weight-loss drugs.
π Key Points Summary
- Ozempic lawsuits have reached 3,763 cases consolidated in Pennsylvania.
- Merck settled over $50 million for Gardasil-related claims.
- The Depo-Provera MDL has grown to over 5,500 cases alleging brain tumors.
- An antitrust lawsuit has been filed against Eli Lilly and Novo Nordisk.
- Ongoing litigation reflects serious concerns about drug safety and competition.
π‘ Tips for Understanding Drug Lawsuits
Review the details of your situation with your attorney.
π Understand Eligibility Criteria
Before pursuing a lawsuit, ensure you meet the eligibility criteria for your specific case. For instance, individuals who developed severe injuries after taking Ozempic may be eligible to file a claim.
β³ Be Aware of Filing Deadlines
Each case has specific filing deadlines. For example, the first Depo-Provera lawsuit was filed on October 1, 2024. Subsequent filings are subject to statutes of limitations, so timely action is crucial.
π Track Legal Proceedings
Stay informed about the progress of ongoing lawsuits. For instance, as of June 2026, no trials have taken place in the Ozempic MDL, with bellwether trials expected to begin in late 2026 or early 2027.
π Seek Support From Nonprofits
Consider reaching out to nonprofit organizations that may provide free legal assistance. They can help guide you through the complexities of product liability claims without the burden of legal fees.
π£οΈ Gather Evidence
Collect and maintain all relevant medical records and documentation of your injuries. This evidence can strengthen your case and support your claims in court.
π Free Options Ranked by User Reviews (2026)
No national paid services met the review threshold for this topic, so this section highlights free government and nonprofit resources that can assist individuals dealing with drug-related lawsuits.
π₯ 1. FDA's Role in Drug Safety
The FDA provides vital information on drug safety and adverse events. This resource helps individuals understand the risks associated with pharmaceuticals, including updates on ongoing investigations and recalls.
- π Who It Helps: Patients seeking information about drug safety can find reliable data to support their claims.
π₯ 2. Legal Aid Organizations
Various nonprofit organizations offer free legal assistance to individuals pursuing product liability claims. These groups help navigate the legal system and provide necessary support.
- π€ Who It Helps: Individuals who may not afford legal services can receive guidance and representation in their lawsuits.
π₯ 3. Public Health Resources
Public health agencies provide information on the safety and efficacy of vaccines and medications. These resources often include updates on lawsuits and safety concerns related to specific drugs.
- π Who It Helps: Patients looking to understand the implications of drug-related injuries can find essential information.
π What to Check Before Paying for Help
- π Confirm the reputation of any service you consider.
- π Look for reviews or testimonials from previous clients.
- π Verify that the service operates within your state or region.
- π« Be wary of any upfront fees or charges for consultations.
β Frequently Asked Questions
β What are the common claims in Ozempic lawsuits?
Many Ozempic lawsuits allege that the drug causes severe gastrointestinal injuries and vision loss. These claims have led to significant legal actions consolidated in federal court.
π§ββοΈ Who is eligible to file a lawsuit against Merck for Gardasil?
Individuals who experienced health issues related to the Gardasil vaccine may be eligible to file a lawsuit. The recent settlement reflects ongoing concerns about its safety.
π₯ How do I know if my Depo-Provera use is linked to brain tumors?
If you have been diagnosed with a brain tumor after using Depo-Provera, you may be eligible to file a lawsuit. Each case will depend on medical documentation and expert opinions.
π° What is the significance of the $50 million Gardasil settlement?
The $50 million settlement indicates Merck's acknowledgment of the legal challenges surrounding Gardasil. It also serves as a warning to other pharmaceutical companies about the risks of litigation.
π When can I expect trials in the Ozempic MDL to begin?
As of June 2026, no trials had taken place in the Ozempic MDL. Bellwether trials are potentially set to begin in late 2026 or early 2027.
π Where can I find more information about ongoing lawsuits?
For updates on ongoing lawsuits, you can refer to legal news sections that cover pharmaceutical litigation, including recent rulings and settlements.
βοΈ Recent Cases Related to Drug Lawsuits
Recent court rulings highlight ongoing litigation concerning pharmaceutical products, including those mentioned in this article.
- Court affirms dismissal of Save Grove Isle's lawsuit against MiamiDistrict Court of Appeal of Florida Β· December 1, 2021
- Court upholds dismissal of Visual Technology's lawsuit against Home DepotDistrict Court of Appeal of Florida Β· May 13, 2020
- Florida court upholds warrantless search in drug caseDistrict Court of Appeal of Florida Β· January 12, 2022
- Florida court affirms ruling in Andre Perry drug caseDistrict Court of Appeal of Florida Β· July 1, 2020
For more recent rulings, check our news section for updates.
End of October 2026 Update
A Brief Guide to Filing a Crestor Lawsuit
What is Crestor?
Crestor, which utilizes the drug Rosuvastatin, is combined with exercise and diet programs to reduce the risk of stroke and heart attack in people who are at risk of developing said diseases. Crestor is also used to decrease cholesterol levels and other fatty substances in the blood in patients 10 years and older. Crestor belongs to a class of medications known as HMG-CoA reductase inhibitors; the drug is effective by slowing cholesterol production in the body to open-up blood blow to the brain, heart and other parts of the body.
Crestor Side Effects:
Crestor, because of its active ingredient (Rosuvastatin) may cause several side effects. Please inform your doctor if any Crestor side effects are severe or persistent:
• Common Crestor Side Effects include: heartburn; dizziness; constipation; depression; joint pain; cough; confusion; memory loss or forgetfulness
Other Crestor side effects are regarded as serious. If you experience any of the following Crestor side effects, please contact your doctor immediately or seek emergency medical help:
• Lack of energy; chest pain; yellowing of the eyes or skin; muscle pain; weakness or tenderness; unusual bruising or bleeding; loss of appetite; extreme fatigue; sore throat or signs of infection; swelling of the face, tongue, lips, hands, feet, lower legs; hoarseness; tingling in toes or fingers and difficulty breathing or swallowing.
Crestor side effects may come in other forms; please contact your doctor if you notice any unusual problems while using the medication.
If you experience serious Crestor side effects, you or your physician may file a report with the United States Food and Drug Administration’s MedWatch Adverse Event Reporting program online at https:///www.fda.gov/safety/medwatch or via the telephone at 1-800-332-1088.
Crestor FDA Regulations:
In March of 2005, the United States Food and Drug Administration released a revised package insert for Crestor. The alterations to the label included results from that revealed a significant link to myopathy/rhabdomyoylsis (muscle toxicity)—this risk, according to studies, is strongest at the highest approved Crstor dosage of 40 mg.
The “dosage and administration” and “warnings” sections of the product label were revised in response to the above study; the revision more strongly reflects the risk of myopathy, particularly at the highest approved dosage of 40 mg.
In 2011, amid an abundance of Crestor lawsuits, the FDA issued follow-up warnings to reflect additional Crestor side effects. The basis for these Crestor lawsuits and subsequent warnings revolved around an increased risk of heart attack and kidney damage.
Crestor Lawsuit:
Even before its release, concerns over Crestor side effects (such as kidney damage) were raised by various consumer groups. Crestor lawsuits, and the increase in Crestor litigation, are natural responses to these reports and the aforementioned warnings issued by the FDA.
The bulk of Crestor lawsuits—and their subsequent results—are kept private and currently there are no pending class action Crestor lawsuits. That being said, it is widely known that hundreds of Crestor lawsuits were filed in the middle of last decade because of the unreported Crestor side effects mentioned above.
A Crestor lawsuit may be pursued if you experience adverse side effects that can indisputably be attributed to Crestor intake. The crux of all Crestor lawsuits revolve around this determination—the plaintiff must prove in his/her Crestor lawsuit that adverse reactions resulted from proper intake of the medication. Moreover, the Crestor lawsuit must be filed within your district’s statute of limitations. Because all potential Crestor lawsuits vary based on circumstances, it is necessary to hire a legal professional who is experienced with similar litigation.
The bulk of Crestor lawsuits were been filed by patients experiencing adverse effects prior to the 2005 FDA label update. The basis for a Crestor lawsuit would claim that the patient was not given adequate warning with regards to the risks of treatment with Crestor. Remember, before embarking on a Crestor lawsuit, please consult with an experienced pharmaceutical or personal injury attorney in your area.
Sources:
1. The United States National Library of Medicine “Rosuvastatin” retrieved from:
https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000242/
2. FDA Public Health Advisory for Crestor (rosuvastatin) retrieved from:
https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/
DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051756.html